Skip to content

WellCareChina

Independent medical information for international patients

Menu

Disease

Colorectal cancer结直肠癌

ICD-10: C18–C20 — Malignant neoplasm of colon, rectosigmoid junction and rectum

Group: Cancer Specialty: Gastrointestinal Surgery, General Surgery

Key figures

Published values only. Every tile opens the section that carries its source, its year and its caliber.

Disease details

Standard Chinese name
结直肠癌
English name
Malignant neoplasm of colon, rectosigmoid junction and rectum

Values written in Chinese are quoted as published by the source.

Also known as

  • CRC
  • Colon cancer
  • Rectal cancer

Treatment cost ranges

Every range below is published on one billing basis: Pre-reimbursement 医保报销前. The sources publish no post-reimbursement figure, so none is shown here.

Treatment path Cost range Price basis Data year
Surgery 手术 48000 – 67000 CNY Condition package price 病种打包全包价 2020–2021
Radiotherapy 放疗 11000 – 50000 CNY Per-item price 项目价 2025–2026
Chemotherapy 化疗 6200 – 9000 CNY Condition package price 病种打包全包价 2020–2021
Targeted therapy 靶向 88000 – 237000 CNY Per-item price 项目价 2025
Immunotherapy 免疫 32043 – 42620 CNY Per-item price 项目价 2024–2025

The bars share one scale across the rows above: each starts at that row's lower published figure and ends at its upper one. The highest upper figure on this page is 237000 CNY. Each row keeps its own data year and caliber.

5 cost ranges for this condition, each with its source on the row page.

Values written in Chinese are quoted as published by the source.

See all cost ranges →

Five-year survival

5-year survival rate 55.7% 95% CI 55.4–55.9

Population
Overall (all stages combined) · Age-standardised relative survival 总体（全分期合并）· 年龄标准化相对生存率
Period
2019–2021
Publisher
National Cancer Center 国家癌症中心
Value nature
Estimated value (hybrid analysis) 估计值（混合法）
Registry scope
281 population-based cancer registries 281 个肿瘤登记处
Stage data availability
Not published by stage (the source publishes the overall figure only)

Values written in Chinese are quoted as published by the source.

See all survival rates →

How to read this figure. It is published for all stages combined, so it is an average over everyone in the national registry data rather than a prognosis for one person. For most cancers, the stage at diagnosis is the strongest single factor behind survival differences: survival is generally higher when the cancer is found at an earlier stage and lower when it is found later. Comparisons between cancers are also shaped by how early or late each one tends to be diagnosed, so a lower figure does not by itself mean worse care.

Hospitals with a published record for this condition

Selected using official public data sources

These hospitals are selected from official public data sources — the Fudan University hospital specialty reputation rankings, the national key clinical specialties list and national clinical research centres — so each line on a card can be checked against its published source. This is not a paid or promoted listing.

How these hospitals were selected

Admission. A hospital is listed for a condition when the specialty that condition is filed under carries at least one of: a place or a nomination in the Fudan University hospital specialty reputation ranking; a national key clinical specialty record at level A, B or C; or a national clinical research centre or a state key laboratory in that specialty. JCI accreditation is shown as a badge; it never decides admission and it never decides order.

Order. Step 1: a Fudan place between 1 and 10 for the specialty. Step 2: another Fudan place, or a nomination. Step 3: a level-A national key clinical specialty. Step 4: a level-B national key clinical specialty. Step 5: a national clinical research centre or a state key laboratory in the specialty, a centre before a laboratory. Step 6: a level-C national key clinical specialty, which is a record we publish without an independent official source and which is therefore listed after the others.

Ties. Within one step: the better Fudan place first, then the stronger key-specialty level (A before B before C), then the province, then the city, then the hospital name - the same province-city-name order the hospital directory uses. At most eight hospitals are listed.

When the list is short. Five hospitals or more: the first eight are listed. Three or four: all of them are listed, and a further fold adds the remaining records up to eight, each carrying its evidence level. One or two: the same, with that fold open and a line stating how many hospitals have a strong public record. None: the page states that no strong public record was found and links to the specialty directory. A place, an institution or a count is never invented to fill the list.

The Fudan rankings are the hospital specialty reputation ranking most widely recognised by Chinese clinicians, published annually by Fudan University's hospital management institute.

  1. Peking Union Medical College Hospital中国医学科学院北京协和医院

    Dongcheng District 东城区

    Fudan specialty reputation ranking 2023

    Also ranked: Urology #8, Gynecology #1, Otorhinolaryngology #4 in the Fudan list.

  2. Zhongshan Hospital复旦大学附属中山医院

    Shanghai 上海市

    Fudan specialty reputation ranking 2023

    National key clinical specialty

    Published research

    1 more published study

    PubMed indexes 3 papers on this condition that name this hospital.

    Also ranked: Thoracic Surgery #6, Gastroenterology #9, Respiratory Medicine #6 in the Fudan list.

  3. West China Hospital, Sichuan University四川大学华西医院

    Chengdu 成都市

    Fudan specialty reputation ranking 2023

    National key clinical specialty

    Also ranked: Thoracic Surgery #4, Urology #2 (tied), Otorhinolaryngology #8 in the Fudan list.

  4. Ruijin Hospital上海交通大学医学院附属瑞金医院

    Shanghai 上海市

    Fudan specialty reputation ranking 2023

    National key clinical specialty

    Published research

    PubMed indexes 2 papers on this condition that name this hospital.

    Also ranked: Thoracic Surgery #7 (tied), Respiratory Medicine #5, Infectious Diseases 传染感染 #6 in the Fudan list.

  5. Chinese PLA General Hospital中国人民解放军总医院

    Beijing 北京市

    Fudan specialty reputation ranking 2023

    Published research

    PubMed indexes 2 papers on this condition that name this hospital.

    Also ranked: Urology #1, Otorhinolaryngology #3, Gastroenterology #4 in the Fudan list.

  6. Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology华中科技大学同济医学院附属同济医院

    Wuhan 武汉市

    Fudan specialty reputation ranking 2023

    National key clinical specialty

    Also ranked: Urology #5, Gynecology #2, Respiratory Medicine #8 in the Fudan list.

  7. The First Affiliated Hospital, Zhejiang University School of Medicine浙江大学医学院附属第一医院

    Hangzhou 杭州市

    Fudan specialty reputation ranking 2023

    National key clinical specialty

    Published research

    PubMed indexes 1 paper on this condition that names this hospital.

    Also ranked: Urology #9, Infectious Diseases 传染感染 #2, Thoracic Surgery nominated in the Fudan list.

  8. The First Affiliated Hospital, Sun Yat-sen University中山大学附属第一医院

    Guangzhou 广州市

    Fudan specialty reputation ranking 2023

    National key clinical specialty

    Published research

    PubMed indexes 2 papers on this condition that name this hospital.

    Also ranked: Gynecology #9, Otorhinolaryngology #5, Gastroenterology #8 in the Fudan list.

Clinical trials (investigational treatments)

In addition to standard care, clinical research studies for Colorectal cancer may currently be open to participants in China. The treatments under study have not been approved by the regulator as standard therapy — they are clinical research, not routine treatment. Each record names the lead investigator and the hospital running the study. If you are interested, contact the hospital to ask about eligibility and choose whether to apply.

  1. Study Clinical Outcomes After Non-curative Endoscopic Resection in Early Colorectal Cancer: A Multicenter Study

    Hospital
    Nanfang Hospital
    Status
    Recruiting
    Registry
    NCT07542171

  2. Study A Multicenter, Prospective, Phase II Exploratory Study on the First-line Treatment of MSS/ PMMR-type Advanced Colorectal Cancer With Adebrelimab Combined With Simvastatin and Targeted and Chemotherapy

    Hospital
    Jiangsu Province Hospital
    Status
    Recruiting
    Registry
    NCT07718490

  3. Study Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Cancer

    Lead investigator
    Qian Peng · chief physician
    Hospital
    Sichuan Cancer Hospital
    Status
    Recruiting
    Registry
    NCT06244537

  4. Study China Colorectal Cancer Screening Trial 1 (C-Cost1): Colonoscopy Versus FIT Versus FIT Plus Blood Test in the Average Risk Population

    Lead investigator
    Ding Ke-Feng · Professor
    Hospital
    Sun Yat-sen University Cancer Center
    Status
    Recruiting
    Registry
    NCT07090291

  5. Study ctDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Single-center, Randomized, Controlled Study

    Lead investigator
    Zhu Yuping · MD
    Hospital
    Zhejiang Cancer Hospital
    Status
    Recruiting
    Registry
    NCT06609551
97 more registered studies

  1. Study Short-Course Radiotherapy Followed by CAPOX With or Without Iparomlimab and Tuvonralimab in pMMR/MSS Locally Advanced Rectal Cancer (SCRIT): A Multicenter Phase III Randomized Controlled Trial

    Lead investigator
    Jinbo Yue · Director of Department Radiation Oncology
    Hospital
    Shandong Cancer Hospital
    Status
    Recruiting
    Registry
    NCT07686640

  2. Study Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cancer (IT-TNT): A Single-arm, Exploratory, Phase II Trial

    Lead investigator
    Jinbo Yue · Director of Radiation Oncology Department
    Hospital
    Shandong Cancer Hospital
    Status
    Recruiting
    Registry
    NCT07026422

  3. Study A Randomized, Multicenter, Controlled Study of Irinotecan Hydrochloride Liposome Injection (Ⅱ) Combined with Fluorouracil, Folinic Acid, Vermofenib and Cetuximab in First-line Treatment of BRAFV600E Mutated Advanced Colorectal Cancer

    Lead investigator
    Yuan-Sheng Zang
    Status
    Recruiting
    Registry
    NCT06603376

  4. Study A Prospective Single-arm Phase II Clinical Study Evaluating Local Methylene Blue Injection for Prevention of Anastomotic Leakage and Permanent Stoma in High-risk Patients With Rectal Cancer Undergoing Low Anterior Resection

    Hospital
    Peking University Cancer Hospital
    Status
    Recruiting
    Registry
    NCT07833319

  5. Study Neoadjuvant Chemotherapy and Tislelizumab (PD-1 Inhibitior) for Locally Advanced Rectal Cancer: a Single-center, Prospective, Phase II Study

    Hospital
    The Affiliated Hospital of Qingdao University
    Status
    Recruiting
    Registry
    NCT06647680

  6. Study A Randomized, Two-Arm, Open-Label Phase II Trial of Low-Dose Radiotherapy Sensitization Combined With Pucotenlimab and CAPEOX as Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Adenocarcinoma

    Lead investigator
    Pei-Rong Ding · Director of the Department of Colorectal Surgery
    Hospital
    Sun Yat-sen University Cancer Center
    Status
    Recruiting
    Registry
    NCT07448142

  7. Study Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer: a Prospective，Multicentre, Single-arm Study

    Status
    Recruiting
    Registry
    NCT06613165

  8. Study The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)

    Lead investigator
    Hu Jiajia · Deputy director
    Hospital
    Ruijin Hospital
    Status
    Recruiting
    Registry
    NCT06601075

  9. Study Survival Benefit of Compound Kushen Injection in Treatment of Advanced Colorectal Cancer Based on Real World Registration Platform

    Lead investigator
    Jie Li · Vice President
    Hospital
    Guang'anmen Hospital of China Academy of Chinese Medical Sciences
    Status
    Recruiting
    Registry
    NCT05894694

  10. Study FOLFOX-Based Transarterial Infusion Chemotherapy for Unresectable Colorectal Cancer: Protocol of an Open-Label, Multicentre, Randomised, Controlled, Phase Ⅱ Trial

    Lead investigator
    Quanda Liu · Chief physician
    Hospital
    Guang'anmen Hospital of China Academy of Chinese Medical Sciences
    Status
    Recruiting
    Registry
    NCT07333053

  11. Study Laparoscopic Ileocecal-Sparing Right Hemicolectomy for Cancer of the Hepatic Flexure and Proximal Transverse Colon -- A Prospective, Multicenter Randomized Control Clinical Trial

    Lead investigator
    Ding Ke-Feng · Professor
    Hospital
    First Affiliated Hospital of Guangzhou Medical University
    Status
    Recruiting
    Registry
    NCT05923255

  12. Study A Single-arm, Single-center Clinical Study of Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer.

    Hospital
    Ningbo Medical Center Lihuili Hospital
    Status
    Recruiting
    Registry
    NCT06613113

  13. Study An Exploratory Study on Gene Methylation Detection of Colorectal Cancer（CRC）

    Lead investigator
    Zhenyuan Qian · associate senior doctor
    Hospital
    Zhejiang Provincial People's Hospital
    Status
    Recruiting
    Registry
    NCT07033156

  14. Study A Phase 1/2, Biomarker-Assigned, Open-Label Dose Escalation and Expansion Study of Allogeneic Dual-Target CAR-NK Cells Targeting CEA (CEACAM5) and/or GUCY2C (GCC) With an Exploratory HER2/ERBB2-Positive Cohort in Subjects With Advanced or Metastatic Colorectal Cancer

    Hospital
    Peking University Shenzhen Hospital
    Status
    Recruiting
    Registry
    NCT07462650

  15. Study A Phase 1/2, Biomarker-Assigned, Open-Label Dose Escalation and Expansion Study of Allogeneic Dual-Target CAR-NK Cells Targeting CEA (CEACAM5) and/or GUCY2C (GCC) With an Exploratory HER2/ERBB2-Positive Cohort in Subjects With Advanced or Metastatic Colorectal Cancer

    Hospital
    Peking University Shenzhen Hospital
    Status
    Recruiting
    Registry
    NCT07589517

  16. Study Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI

    Lead investigator
    xiaochun meng · The Director of Diagnostic Radiology Department
    Hospital
    The Sixth Affiliated Hospital, Sun Yat-sen University
    Status
    Recruiting
    Registry
    NCT05523245

  17. Study Laparoscopic Rectal Irrigation for the Prevention of Local Recurrence After Radical Resection of Mid-to-Low Rectal Cancer: A Prospective, Multicenter, Randomized, Open-label, Parallel-controlled Clinical Study

    Lead investigator
    Yanhong Deng · chief physician
    Hospital
    The Sixth Affiliated Hospital, Sun Yat-sen University
    Status
    Recruiting
    Registry
    NCT07512232

  18. Study Effects of Preoperative Oral Mmidazolam on Postoperative Pain in Sleep Disturbance or Anxiety Patients Undergoing Laparoscopic Colorectal Cancer Resection- A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Study

    Lead investigator
    SanQing Jin · professor
    Hospital
    The Sixth Affiliated Hospital, Sun Yat-sen University
    Status
    Recruiting
    Registry
    NCT06407518

  19. Study Toripalimab Plus Celecoxib With Response-adapted Non-operative Management for Mismatch Repair-deficient or Microsatellite Instability-high Locally Advanced Colorectal Cancer (PICC-3): a Multicenter, Single-arm, Phase 2 Trial

    Lead investigator
    Yanhong Deng · Professor
    Hospital
    The Sixth Affiliated Hospital, Sun Yat-sen University
    Status
    Recruiting
    Registry
    NCT06903858

  20. Study A Prospective, Randomized, Open, Parallel-controlled, Superiority Clinical Study of Radical Right Hemicolectomy Versus Radical Right Hemicolectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracer Dissection for the Treatment of Right Colon Cancer

    Lead investigator
    Yanhong Deng · chief physician
    Hospital
    The Sixth Affiliated Hospital, Sun Yat-sen University
    Status
    Recruiting
    Registry
    NCT06485609

  21. Study Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer: A Prospective, Single-arm, Phase II Study

    Hospital
    The Sixth Affiliated Hospital, Sun Yat-sen University
    Status
    Recruiting
    Registry
    NCT07297004

  22. Study Neoadjuvant Chemoradiotherapy Plus Sintilimab for Intermediate/High Immunoscore Locally Advanced Rectal Cancer: A Single-Center, Open-Label, Single-Arm, Phase 2 Trial

    Lead investigator
    Yanhong Deng · Professor
    Hospital
    The Sixth Affiliated Hospital, Sun Yat-sen University
    Status
    Recruiting
    Registry
    NCT05450029

  23. Study A Randomized, Open-label Phase 3 Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

    Hospital
    Peking University First Hospital
    Status
    Recruiting
    Registry
    NCT06662786

  24. Study Transanal Versus Laparoscopic Total Mesorectal Excision for Mid and Low Rectal Cancer (TaLaR): a Multicentre Randomised Clinical Trial

    Lead investigator
    Yanhong Deng · MD
    Hospital
    Peking Union Medical College Hospital
    Status
    Recruiting
    Registry
    NCT02966483

  25. Study An Exploratory Study Investigating the Combination of Chidamide, Regorafenib, Plus Iparomlimab and Tuvonralimab for the Treatment of Drug-esistant and Efractory Dvanced Colorectal Cancer

    Status
    Recruiting
    Registry
    NCT06930118

  26. Study Phase II Study of Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer

    Lead investigator
    Zhan Wang
    Status
    Recruiting
    Registry
    NCT07398326

  27. Study CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Locally Recurrent Colorectal Cancer

    Status
    Recruiting
    Registry
    NCT06881537

  28. Study A Dose-expansion Trial Exploring the Safety and Efficacy of Intravenous HNF4α srRNA in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer

    Lead investigator
    Wei-Fen Xie
    Status
    Recruiting
    Registry
    NCT07050394

  29. Study Multi-omics Study for Early Detection of Colorectal Cancer Based on Liquid Biopsy Technology

    Lead investigator
    Ding Ke-Feng · Chief physician
    Hospital
    The Second Affiliated Hospital Zhejiang University School of Medicine
    Status
    Recruiting
    Registry
    NCT06220617

  30. Study A Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1 Monoclonal Antibody and Chidamide in Refractory MSS Metastatic Colorectal Cancer

    Lead investigator
    Wang Chang · Director
    Hospital
    The First Hospital of Jilin University
    Status
    Recruiting
    Registry
    NCT06979908

  31. Study Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria

    Lead investigator
    Pengyu Chang · Chief Physician
    Hospital
    The First Hospital of Jilin University
    Status
    Recruiting
    Registry
    NCT07505472

  32. Study A Prospective Study of Levoleucovorin/5-FU Co-Infusion Combined With Liposomal Irinotecan ±Cetuximab/Bevacizumab as Second-Line Therapy for MSS Metastatic Colorectal Cancer

    Hospital
    The First Hospital of Jilin University
    Status
    Recruiting
    Registry
    NCT07559760

  33. Study Efficacy and Safety of Neoadjuvant Long-course Chemoradiation Plus Tislelizumab in Mid-low Locally Advanced Rectal Cancer: a Phase II, Multi-center, Open-label, Randomized Controlled Trial (POLARSTAR Trial)

    Lead investigator
    Zhongtao Zhang · Director
    Hospital
    Beijing Friendship Hospital, Capital Medical University
    Status
    Recruiting
    Registry
    NCT05245474

  34. Study Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer

    Lead investigator
    Lin Wang · Unit III & Ostomy Service, Gastrointestinal Cancer Center
    Hospital
    Peking University Cancer Hospital
    Status
    Recruiting
    Registry
    NCT06209099

  35. Study Samples Procurement for Patients With Colorectal Cancer, Gastric Cancer, and Non-malignant Disease Undergoing Surgery

    Lead investigator
    Tao Fu · Director of Department of GI Surgery II
    Hospital
    Renmin Hospital of Wuhan University
    Status
    Recruiting
    Registry
    NCT03972956

  36. Study Node-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Middle and Low Rectal Cancer (mRCAT-E): An Open-label, Single-arm, Prospective Multicenter Clinical Trial

    Lead investigator
    Zhangfa Song · Vice president
    Hospital
    Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine
    Status
    Recruiting
    Registry
    NCT07068763

  37. Study Circulating Tumor DNA Methylation Guiding Postoperative Adjuvant Chemotherapy in Stage III Colorectal Cancer: a Multicenter, Randomized Controlled Trial

    Lead investigator
    Zhangfa Song · Vice director
    Hospital
    Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine
    Status
    Recruiting
    Registry
    NCT06167967

  38. Study An Open-label Randomized Phase 3 Study of Tucatinib in Combination With Trastuzumab and mFOLFOX6 Versus mFOLFOX6 Given With or Without Either Cetuximab or Bevacizumab as First-line Treatment for Subjects With HER2+ Metastatic Colorectal Cancer

    Hospital
    Fujian Medical University Union Hospital
    Status
    Recruiting
    Registry
    NCT05253651

  39. Study A Phase II, Multicenter, Open Label, Parallel Cohort Clinical Trial to Evaluate the Efficacy and Safety of PM8002 (BNT327) in Combination With Chemotherapy in First Line MSS or MSI-L/pMMR Metastatic Colorectal Cancer

    Hospital
    Peking University First Hospital
    Status
    Recruiting
    Registry
    NCT07133750

  40. Study TME vs TME+nCT in Low-risk LARC

    Lead investigator
    Yanhong Deng
    Status
    Recruiting
    Registry
    NCT05984485

  41. Study An Open-Label, Randomized, Controlled, Global Phase 3 Study Comparing Telisotuzumab Adizutecan (ABBV-400) Plus Bevacizumab to LONSURF (Trifluridine and Tipiracil) Plus Bevacizumab in Subjects With Refractory Metastatic Colorectal Cancer

    Hospital
    Beijing Hospital
    Status
    Recruiting
    Registry
    NCT07525206

  42. Study The Effectiveness of Deferred Adjuvant Therapy Guided by Dynamic Monitoring Minimal Residue Disease in Resectable High-risk Stage II and Low-risk Stage III Colon Cancer: an Open-label, Multicenter, Phase II Clinical Study

    Lead investigator
    Gong Chen · Professor
    Hospital
    Sun Yat-sen University Cancer Center
    Status
    Recruiting
    Registry
    NCT06204484

  43. Study Irinotecan in Combination With Trifluridine-tipiracil and Bevacizumab in Pre-treated Metastatic Colorectal Cancer

    Hospital
    Qilu Hospital of Shandong University
    Status
    Recruiting
    Registry
    NCT06242067

  44. Study Hypofractionated Radiotherapy Combined With Irinotecan Hydrochloride Liposome, 5-FU, Leucovorin, PD-1 Antibody and Target Therapy in Locally Recurrent Rectal Cancer(NOVELTY-R)

    Lead investigator
    Zhen Zhang · Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
    Hospital
    Fudan University Shanghai Cancer Center
    Status
    Recruiting
    Registry
    NCT07183865

  45. Study Use of Probe-based Confocal Laser Endomicroscopy to Perform Targeted Optical Biopsy for Local Rectal Scars in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy

    Hospital
    Nanfang Hospital
    Status
    Recruiting
    Registry
    NCT05316103

  46. Study Right Gastroepiploic Mesentery Metastasis in Advanced Colon Cancer Locating at or Close to the Hepatic Flexure

    Lead investigator
    Jichao Qin · Professor
    Hospital
    Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
    Status
    Recruiting
    Registry
    NCT04980287

  47. Study A Randomized, Open Label, 3-arm Phase 3 Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

    Hospital
    Sun Yat-sen University Cancer Center
    Status
    Recruiting
    Registry
    NCT07549412

  48. Study Clinical Study of Second-line Treatment of Patients With Advanced Colorectal Cancer With Irinotecan Liposome (II), Fluorouracil in Combination With Bevacizumab or Cetuximab

    Hospital
    The Second Affiliated Hospital Zhejiang University School of Medicine
    Status
    Recruiting
    Registry
    NCT06540326

  49. Study Trifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic Colorectal Cancer: A Randomized, Controlled, Open-Label, Non-Inferiority Trial

    Hospital
    The Second Affiliated Hospital Zhejiang University School of Medicine
    Status
    Recruiting
    Registry
    NCT06992648

  50. Study Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node, a Prospective, Multicenter, Non-inferior Randomized Controlled Trial

    Lead investigator
    QIAN LIU · Professor
    Hospital
    Peking Union Medical College Hospital
    Status
    Recruiting
    Registry
    NCT06146946

  51. Study A Prospective, Multicenter, Randomized, Parallel Controlled Study Comparing Huaier Granules With Capecitabine Monotherapy for the Prevention of Recurrence and Metastasis After Radical Resection of Stage II Colorectal Cancer

    Lead investigator
    Sanjun Cai · professor
    Hospital
    Third Affiliated Hospital of Harbin Medical University
    Status
    Recruiting
    Registry
    NCT06090994

  52. Study A Phase Ib/II Clinical Study to Evaluate the Efficacy and Safety of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in Participants With HER2-Abnormally Expressed Unresectable Locally Advanced or Metastatic Colorectal Cancer.

    Hospital
    Peking University First Hospital
    Status
    Recruiting
    Registry
    NCT07653685

  53. Study A Phase Ib/II Clinical Study Evaluating TQB2922 for Injection and Chemotherapy in Combination With or Without Bevacizumab in Subjects With RAS/BRAF Wild-Type Advanced Colorectal Cancer Who Have Failed Chemotherapy

    Hospital
    The First Affiliated Hospital of Anhui Medical University
    Status
    Recruiting
    Registry
    NCT07044908

  54. Study Open, Parallel, Randomized Controlled, Non-inferior, Phase III Clinical Research on the Treatment Model of Ambulatory Surgery for Colorectal Cancer

    Lead investigator
    Kai Li · Deputy Director of surgical Oncology
    Hospital
    First Hospital of China Medical University
    Status
    Recruiting
    Registry
    NCT06637215

  55. Study A Randomized, Open-label Phase 3 Study of Amivantamab + FOLFIRI Versus Cetuximab/Bevacizumab + FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Recurrent, Unresectable or Metastatic Colorectal Cancer Who Have Received Prior Chemotherapy

    Hospital
    Peking University First Hospital
    Status
    Recruiting
    Registry
    NCT06750094

  56. Study A Study to Evaluate the Efficacy and Safety of a First-line Treatment for Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU

    Lead investigator
    Dai, Guanghai · Professor
    Hospital
    Chinese PLA General Hospital
    Status
    Recruiting
    Registry
    NCT07391618

  57. Study Efficacy and Safety of Preoperative (Chemo)Radiotherapy for Locally Recurrent Rectal Cancer: A Prospective, Single-arm Observational Study

    Hospital
    The Sixth Affiliated Hospital, Sun Yat-sen University
    Status
    Not yet recruiting
    Registry
    NCT06617052

  58. Study Construction and Empirical Research of the Applicable Baduanjin Protocol for Patients With Colorectal Cancer Enterostomy

    Lead investigator
    Hui Yang · principal investigator
    Hospital
    Sichuan Cancer Hospital
    Status
    Not yet recruiting
    Registry
    NCT07172087

  59. Study A Non-randomised External Controlled Trial of Gum Chewing to Enhance the Restoration of Intestinal Motility in Colorectal Surgery

    Lead investigator
    Hui Yang · Principal Investigator
    Hospital
    Sichuan Cancer Hospital
    Status
    Not yet recruiting
    Registry
    NCT06860685

  60. Study A Prospective Single-Center Observational Study Evaluating Concordance Between Large Language Model-Generated Recommendations and Multidisciplinary Team Recommendations in Rectal Cancer

    Lead investigator
    Jinbo Yue · Professor
    Hospital
    Shandong Cancer Hospital
    Status
    Not yet recruiting
    Registry
    NCT07595107

  61. Study Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal High-Risk or Very High-Risk Patients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Study

    Lead investigator
    Quan Wang · Prof.
    Hospital
    The First Hospital of Jilin University
    Status
    Not yet recruiting
    Registry
    NCT05998122

  62. Study A Prospective, Phase II, Single-Arm Study on the Efficacy and Safety of Neoadjuvant Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

    Lead investigator
    Yingchi Yang · Professor
    Hospital
    Beijing Friendship Hospital, Capital Medical University
    Status
    Not yet recruiting
    Registry
    NCT07397442

  63. Study Development and Validation of a Colorectal Cancer Diagnostic Model: A Multicenter Study in China (CCDM-CN)

    Hospital
    Peking University Cancer Hospital
    Status
    Not yet recruiting
    Registry
    NCT07692555

  64. Study Comparison of Large Language Models and Expert Multidisciplinary Team Decisions in Colorectal Cancer

    Hospital
    Peking University Cancer Hospital
    Status
    Not yet recruiting
    Registry
    NCT07045207

  65. Study Phase Ib/II Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Efficacy of MRG007 Combination Therapy in Patients With Advanced Colorectal Cancer

    Hospital
    Peking University Cancer Hospital
    Status
    Not yet recruiting
    Registry
    NCT07737600

  66. Study A Phase II Clinical Study of FULIRI Regimen Chemotherapy Combined With Targeted Therapy for First-line Conversion Treatment of Colorectal Cancer Liver Metastases.

    Hospital
    Zhongnan Hospital of Wuhan University
    Status
    Not yet recruiting
    Registry
    NCT07515963

  67. Study PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSS

    Lead investigator
    Yong Li, MD · Chief Physician of Gastrointestinal Surgery
    Hospital
    Guangdong Provincial People's Hospital
    Status
    Not yet recruiting
    Registry
    NCT06391905

  68. Study A Single-Arm, Phase II, Multicenter Study of Serplulimab Combined With CAPOX Plus Bevacizumab as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

    Status
    Not yet recruiting
    Registry
    NCT07819604

  69. Study A Phase III Randomized Controlled Clinical Study Comparing BL-M07D1 With Physician's Choice Therapy in Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Failed Prior Treatment With Oxaliplatin, Fluorouracil and Irinotecan

    Hospital
    First Hospital of China Medical University
    Status
    Not yet recruiting
    Registry
    NCT07730489

  70. Study Exploratory Clinical Study of SHR-A1811 Combined with Apatinib in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma and Colorectal Cancer

    Lead investigator
    Yunpeng Liu · Professor
    Hospital
    First Hospital of China Medical University
    Status
    Not yet recruiting
    Registry
    NCT06666166

  71. Study A Single-Arm, Phase II Study of Retlirafusp Alfa in Combination With XELOX and Bevacizumab for the First-Line Treatment of Advanced RAS-Mutated Colorectal Cancer With Liver Metastases (CRLM)

    Lead investigator
    Dai, Guanghai · Professor,Chief Physician
    Hospital
    Chinese PLA General Hospital
    Status
    Not yet recruiting
    Registry
    NCT07797244

  72. Study Exploring the Effects of Magnesium Ions on Peripheral Neuropathy, Serum Magnesium Ion Concentration,Sleep Quality, and Quality of Life in Patients With Colorectal Cancer Receiving Chemotherapy.

    Hospital
    Kaohsiung Medical University Chung-Ho Memorial Hospital
    Status
    Not yet recruiting
    Registry
    NCT07346469

  73. Study A Prospective, Multicenter, Single-Arm Phase II Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (cT1-3N0M0)

    Lead investigator
    Bo Yi · Chief Physician
    Hospital
    Chongqing University Cancer Hospital
    Status
    Not yet recruiting
    Registry
    NCT07543848

  74. Study A Prospective Single-Arm Phase II Clinical Study of Neoadjuvant Short-Course Radiotherapy With Simultaneous Integrated Boost Combined With Capecitabine-Oxaliplatin and PD-1 Inhibitor Therapy in High-Risk Locally Advanced Rectal Cancer

    Lead investigator
    Yanhong Deng · M.D.
    Hospital
    The Sixth Affiliated Hospital, Sun Yat-sen University
    Status
    Not yet recruiting
    Registry
    NCT07297030

  75. Study A Prospective, Single-arm, Multicenter Phase II Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer

    Lead investigator
    Liangjun Zhu M.M. · Chief Physician, Department of Medical Oncology
    Hospital
    Jiangsu Cancer Hospital
    Status
    Not yet recruiting
    Registry
    NCT07446387

  76. Study A Randomized, Multicenter Clinical Study of Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer

    Lead investigator
    Ji Zhu · Coordinating Investigator
    Hospital
    Zhejiang Cancer Hospital
    Status
    Not yet recruiting
    Registry
    NCT07074353

  77. Study A Randomized Controlled Trial of Fluorescence Laparoscopic Navigation of the Extent of Lymph Node Dissection for High Rectal Cancer and Sigmoid Colon Cancer

    Lead investigator
    Jianqiang Tang · Associate professor
    Hospital
    Anhui Provincial Hospital
    Status
    Not yet recruiting
    Registry
    NCT05730595

  78. Study Effect of an Individualized Urinary Catheter Management Strategy on the Safety and Efficacy of Early Catheter Removal After Mid-Low Rectal Cancer Surgery: A Single-Center Randomized Controlled Trial

    Lead investigator
    Yuchen Guo, Ph.D. · Prof.
    Hospital
    The First Hospital of Jilin University
    Status
    Not yet recruiting
    Registry
    NCT07346586

  79. Study To Explore a Single-arm Phase II Study on Intestinal Microbiota Transplantation Combined With Neoadjuvant Immunotherapy and Chemoradiotherapy for Locally Advanced Rectal Cancer Under MSS/pMMR

    Hospital
    Tianjin Medical University Cancer Institute & Hospital
    Status
    Not yet recruiting
    Registry
    NCT07738042

  80. Study The Safety and Efficacy of Autologous Probiotics in Patients With Defunctioning Ileostomy Following Low Anterior Resection for Rectal Cancer.

    Lead investigator
    Lin Wang · surgeon-in-charge
    Hospital
    Peking University Cancer Hospital
    Status
    Not yet recruiting
    Registry
    NCT07366047

  81. Study SHR-A1904 in Advanced Colorectal Cancer: an Exploratory Study

    Lead investigator
    Jian Li · Chief Physician
    Hospital
    Peking University Cancer Hospital
    Status
    Not yet recruiting
    Registry
    NCT07700719

  82. Study Non-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI Cancers (NOMIC Trial)

    Lead investigator
    Xiaokang Lei · Principal Investigator
    Hospital
    Peking University Cancer Hospital
    Status
    Not yet recruiting
    Registry
    NCT07656740

  83. Study A Phase II Study Evaluating the Efficacy and Safety of Neoadjuvant Therapy With MRI-Guided Involve-site Short-Course Radiotherapy Combined With Immunotherapy and Chemotherapy for Locally Advanced Rectal Cancer

    Lead investigator
    Longhao Li · M.D.
    Hospital
    The First Affiliated Hospital of Chongqing Medical University
    Status
    Not yet recruiting
    Registry
    NCT07161115

  84. Study An Intelligent Voice-interactive Tailored Communication System (ScreenTalk) for Enhancing Colorectal Cancer Screening Among First-degree Relatives of Patients: a Randomized Type I Hybrid Effectiveness-implementation Trial

    Lead investigator
    Yang Bai · Associate Professor
    Hospital
    Sun Yat-sen University Cancer Center
    Status
    Not yet recruiting
    Registry
    NCT06710860

  85. Study The Identification, Validation and Implementation of Molecular Markers to Predict Response to Fluorouracil-based Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients - Prospective Clinical Observational Study

    Lead investigator
    Tao Fu · Head of Department of GI Surgery II
    Hospital
    Renmin Hospital of Wuhan University
    Status
    Not yet recruiting
    Registry
    NCT03127111

  86. Study Safety and Efficacy Study of Single-port Robotic Versus Multi-port Robotic Radical Rectal Cancer Surgery: A Multi-center, Prospective, Open Label, Non-inferiority, Randomized Controlled Trial

    Lead investigator
    Zhao Ren · Chief Physicion
    Hospital
    First Affiliated Hospital of Guangzhou Medical University
    Status
    Not yet recruiting
    Registry
    NCT06943690

  87. Study Comparison of Short- and Long-term Outcomes Between Robotic and Laparoscopic Hemicolectomy of Right Colon Cancer : A Multicenter Propensity Score Matching Analysis

    Lead investigator
    Taiyuan Li · chief physician
    Hospital
    The First Affiliated Hospital of Nanchang University
    Status
    Not yet recruiting
    Registry
    NCT07029464

  88. Study QL1706 Combined With Standard Therapy for Conversion Therapy of Synchronous Liver Metastases From Colon Cancer: a Multicenter, Single-arm, Exploratory Study

    Lead investigator
    Xi Shi · MD
    Hospital
    The First Affiliated Hospital of Fujian Medical University
    Status
    Not yet recruiting
    Registry
    NCT07649473

  89. Study Node-sparing Modified Short-Course Radiation Combined With CAPOX and Sintilimab for MSS Locally Advanced Colon Cancer : A Randomized, Prospective, Multicenter, Open-label Clinical Trial

    Lead investigator
    Zhangfa Song · Professor
    Hospital
    Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine
    Status
    Not yet recruiting
    Registry
    NCT06594692

  90. Study A Prospective, Multicenter, Randomized Controlled Trial of the Effectiveness of Robotic Versus Laparoscopic Surgery for Right Colon Cancer

    Lead investigator
    Zhangfa Song · Professor
    Hospital
    Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine
    Status
    Not yet recruiting
    Registry
    NCT06421974

  91. Study Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer

    Hospital
    Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine
    Status
    Not yet recruiting
    Registry
    NCT06079242

  92. Study Short-Course Radiotherapy Followed by Liposomal Irinotecan, Capecitabine, and Camrelizumab as Neoadjuvant Therapy for Locally Advanced pMMR/MSS Low Rectal Cancer: A Prospective Single-Arm Phase II Trial Protocol

    Hospital
    Guangdong Provincial People's Hospital
    Status
    Not yet recruiting
    Registry
    NCT07521605

  93. Study Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial

    Hospital
    Guangdong Provincial People's Hospital
    Status
    Not yet recruiting
    Registry
    NCT07686796

  94. Study A Single-Arm, Exploratory Study of Iparomlimab and Tuvonralimab (QL1706) Plus XELOX as Neoadjuvant Therapy in Patients With Microsatellite Stable (pMMR/MSS) Resectable Stage III Colon Cancer

    Lead investigator
    Jing Hao · Deputy Director, Department of Oncology
    Hospital
    Qilu Hospital of Shandong University
    Status
    Not yet recruiting
    Registry
    NCT07156682

  95. Study Multicenter Clinical Validation of a Novel Strategy for Early Diagnosis and Recurrence Monitoring in Colorectal Cancer

    Lead investigator
    Jie Liu · Professor
    Hospital
    Huashan Hospital
    Status
    Not yet recruiting
    Registry
    NCT06991452

  96. Study Preservation Versus Dissection of Inferior Mesenteric Artery Lymph Nodes of Robotic Radical Resection for Mid/Low Rectal Cancer (REAL2): A Multicenter Randomized Controlled Trial

    Lead investigator
    Xu jianmin · Chair of Colorectal Surgery Department
    Hospital
    Zhongshan Hospital
    Status
    Not yet recruiting
    Registry
    NCT06956976

  97. Study Savolitinib Plus Cetuximab and FOLFOX Chemotherapy Versus Cetuximab and FOLFOX Chemotherapy as First-line Treatment for RAS/BRAF Wild-type Metastatic Colorectal Cancer: a Prospective, Randomized, Controlled, Multicenter, Open-label Study

    Lead investigator
    Xu jianmin
    Status
    Not yet recruiting
    Registry
    NCT07683403

This page only shares publicly registered study information. It does not recommend or encourage joining any study. Participation is entirely voluntary and the risks of an unapproved treatment are unknown; contact the hospital directly for eligibility and informed-consent details.

Hospitals with a national key specialty record

Show the hospital records 50 hospitals with a key-specialty record

Each row is a hospital with a national key clinical specialty record in a specialty this condition is filed under. This is a record of published listings, not a recommendation and not a ranking.

Hospital City Specialty (as published) Evidence Source
Renji Hospital, Shanghai Jiao Tong University School of Medicine上海交通大学医学院附属仁济医院 Shanghai 上海市 General Surgery 普外科 Level B https://www.renji.com/gh/article/list/01/01
XinHua Hospital上海交通大学医学院附属新华医院 Shanghai 上海市 General Surgery 普外科 Level B https://www.xinhuamed.com.cn/?channel=hot
Ruijin Hospital上海交通大学医学院附属瑞金医院 Shanghai 上海市 General Surgery 普外科 Level B https://www.rjh.com.cn/2018RJPortal/lcyxy2019/sy/jj/index.shtml
Shanghai General Hospital上海市第一人民医院 Shanghai 上海市 General Surgery 普外临床医学中心 Level B https://www.firsthospital.cn/List/Depart/f0
Zhongshan Hospital复旦大学附属中山医院 Shanghai 上海市 General Surgery 普通外科 Level B https://www.zs-hospital.sh.cn/zhuanye/content/5140.html
Cancer Hospital of Chinese Academy of Medical Sciences中国医学科学院肿瘤医院 Beijing 北京市 Gastrointestinal Surgery 结直肠外科 Level B https://www.cicams.ac.cn/news/401.html
China-Japan Friendship Hospital中日友好医院 Beijing 北京市 Gastrointestinal Surgery 肛肠科 Level B https://www.zryhyy.com.cn/zryh/c100020/202309/47e8245aa93343baac89762d4e80580f.shtml
Beijing Hospital北京医院 Beijing 北京市 General Surgery 普通外科 Level B https://www.bjhmoh.cn/index.php?id=4&r=archives/about&t=1790009033
Peking University People's Hospital北京大学人民医院 Beijing 北京市 General Surgery 普外科 Level B https://www.pkuph.cn/news_details/26715.html
Peking University First Hospital北京大学第一医院 Beijing 北京市 General Surgery 普通外科 Level B https://www.pkufh.com/Html/News/Articles/64494.html
Peking University Third Hospital北京大学第三医院 Beijing 北京市 General Surgery 普通外科 Level B https://www.puh3.net.cn/yygk/zdxk.htm
Beijing Friendship Hospital, Capital Medical University首都医科大学附属北京友谊医院 Beijing 北京市 General Surgery 普通外科 Level A https://ygch.ccmu.edu.cn/lcxkjz/xkpt/gjlczdzk/index.htm
West China Hospital, Sichuan University四川大学华西医院 Chengdu 成都市 General Surgery 普通外科 · Gastrointestinal Surgery 结直肠肿瘤中心 Level A https://wcums.scu.edu.cn/kxyan_jiu/gjlczdzk.htm
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital四川省医学科学院·四川省人民医院 Chengdu 成都市 General Surgery 普通外科 Level B https://www.samsph.com/news_hos/2023/xe7kw1e7.html
Sichuan Cancer Hospital四川省肿瘤医院 Chengdu 成都市 General Surgery 普通外科 Level B https://www.sichuancancer.org/yygk/yyjs.htm
Tianjin Medical University General Hospital天津医科大学总医院 Tianjin 天津市 General Surgery 普通外科 Level B https://www.tjmugh.com.cn/system/2019/01/02/020008655.shtml
Anhui Provincial Hospital中国科学技术大学附属第一医院（安徽省立医院） Hefei 合肥市 General Surgery 普外科 Level B https://www.ahslyy.com.cn/nanqu/col456/892156
The First Affiliated Hospital of Anhui Medical University安徽医科大学第一附属医院 Hefei 合肥市 General Surgery 普外科 Level B https://www.ayfy.com/info/1184/27750.htm
The Second Hospital of Shandong University山东大学第二医院 Jinan 济南市 General Surgery 普通外科 Level A https://file.byfy.cn/Resource/File/Upload/file/20251203/20251203160857_1590.pdf
Qilu Hospital of Shandong University山东大学齐鲁医院 Jinan 济南市 General Surgery 普通外科 Level B https://www.qiluhospital.com/index.php?m=content&c=index&a=show&catid=681&id=33049
Shandong Provincial Qianfoshan Hospital山东省千佛山医院 Jinan 济南市 General Surgery 普通外科 Level A https://file.byfy.cn/Resource/File/Upload/file/20251203/20251203160857_1590.pdf
Shandong Provincial Hospital山东省立医院 Jinan 济南市 General Surgery 普通外科 Level A http://wsjkw.shandong.gov.cn/zwgk/fdzdgknr/gsgg/202406/t20240613_4736124.html
Shandong Cancer Hospital山东省肿瘤医院 Jinan 济南市 General Surgery 普通外科 Level A http://wsjkw.shandong.gov.cn/zwgk/fdzdgknr/gsgg/202406/t20240613_4736124.html
Sun Yat-sen Memorial Hospital, Sun Yat-sen University中山大学孙逸仙纪念医院 Guangzhou 广州市 General Surgery 普通外科 Level B https://www.gzsys.org.cn/basic/453
Sun Yat-sen University Cancer Center中山大学肿瘤防治中心 Guangzhou 广州市 General Surgery 普通外科 Level B https://www.sysucc.org.cn/node/8565
The First Affiliated Hospital, Sun Yat-sen University中山大学附属第一医院 Guangzhou 广州市 General Surgery 普通外科 Level B https://gcp.fahsysu.org.cn/sites/1h.gcp.sysucloud1.sysu.edu.cn/files/2023-07/20230625%20中山大学附属第一医院宣传折页%20V5.0_0.pdf
The Third Affiliated Hospital of Sun Yat-sen University中山大学附属第三医院 Guangzhou 广州市 General Surgery 普通外科 Level B https://www.zssy.com.cn/basic/468
Nanfang Hospital南方医科大学南方医院 Guangzhou 广州市 General Surgery 普通外科 Level B https://www.nfyy.com/index.html
Guangdong Provincial People's Hospital广东省人民医院 Guangzhou 广州市 General Surgery 普外科 Level B https://www.gdghospital.org.cn/newshospital/info_itemid_32986.html
Nanjing Drum Tower Hospital南京鼓楼医院（南京大学医学院附属鼓楼医院） Nanjing 南京市 General Surgery 普通外科 Level B https://www.njglyy.com/zbmz/zbmz2.aspx
Henan Provincial People's Hospital河南省人民医院 Zhengzhou 郑州市 General Surgery 普通外科专业 Level C Not published
Henan Cancer Hospital河南省肿瘤医院 Zhengzhou 郑州市 General Surgery 普外科 Level B https://anti-cancer.com.cn/Mobile/Journal/ArticleIndex/2171
First Affiliated Hospital of Zhengzhou University郑州大学第一附属医院 Zhengzhou 郑州市 General Surgery 普通外科 Level B https://www.zdyfy.cn/tsyl/gjjlczdzk
The First Affiliated Hospital, Zhejiang University School of Medicine浙江大学医学院附属第一医院 Hangzhou 杭州市 General Surgery 普通外科 Level A http://zdygb.zju.edu.cn/2014/0106/c34026a1762975/page.htm
The Second Affiliated Hospital Zhejiang University School of Medicine浙江大学医学院附属第二医院 Hangzhou 杭州市 General Surgery 普通外科 Level A http://zdygb.zju.edu.cn/2014/0106/c34026a1762975/page.htm
Sir Run Run Shaw Hospital Affiliated with Zhejiang University School of Medicine浙江大学医学院附属邵逸夫医院 Hangzhou 杭州市 General Surgery 普通外科学 Level A http://zdygb.zju.edu.cn/2014/0106/c34026a1762975/page.htm
Zhejiang Provincial People's Hospital浙江省人民医院 Hangzhou 杭州市 General Surgery 普通外科 Level B https://hospitalstar.com/#/intro/courtyard?id=1&cid=204&fnav=2
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology华中科技大学同济医学院附属协和医院 Wuhan 武汉市 General Surgery 普外科 Level B https://www.whuh.com/kxyj/xkjs/gjlczdzk/2.htm
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology华中科技大学同济医学院附属同济医院 Wuhan 武汉市 General Surgery 普通外科：甲乳外科 · Gastrointestinal Surgery 普通外科：胃肠外科 Level B https://www.tjh.com.cn/contents/934/27291.html
Zhongnan Hospital of Wuhan University武汉大学中南医院 Wuhan 武汉市 General Surgery 普通外科 Level B https://www.znhospital.com/Uploads/Picture/2025/03/06/u67c8f245cacb9.pdf
Third Xiangya Hospital中南大学湘雅三医院 Changsha 长沙市 General Surgery 普通外科 Level B https://www.xy3yy.com/ksjj/184173.html
Second Xiangya Hospital of Central South University中南大学湘雅二医院 Changsha 长沙市 General Surgery 普通外科 Level B https://www.xyeyy.com/655/656/664/
Xiangya Hospital of Central South University中南大学湘雅医院 Changsha 长沙市 General Surgery 普通外科 Level B https://www.xiangya.com.cn/zdzk.html
Shengjing Hospital中国医科大学附属盛京医院 Shenyang 沈阳市 General Surgery 普通外科 Level B https://www.sj-hospital.cn/article/82.html
First Hospital of China Medical University中国医科大学附属第一医院 Shenyang 沈阳市 General Surgery 普通外科 Level B https://www.cmu1h.com/features/specialty
The First Affiliated Hospital of Chongqing Medical University重庆医科大学附属第一医院 Chongqing 重庆市 General Surgery 普通外科 Level B https://www.hospital-cqmu.com/gzb/yygk/yyjj.htm
The Second Affiliated Hospital of Chongqing Medical University重庆医科大学附属第二医院 Chongqing 重庆市 General Surgery 普通外科 Level A https://wsjkw.cq.gov.cn/zwgk_242/fdzdgknr/tzgg/gzgs/202412/t20241225_14021980_wap.html
Chongqing General Hospital重庆市人民医院 Chongqing 重庆市 General Surgery 普通外科 Level B https://www.cghhospital.org/into_hos
The First Affiliated Hospital of Xi'an Jiaotong University西安交通大学第一附属医院 Xi'an 西安市 General Surgery 普通外科 Level B https://news.xjtu.edu.cn/info/1033/17951.htm
Shaanxi Provincial People's Hospital陕西省人民医院 Xi'an 西安市 Gastrointestinal Surgery 胃肠外科 Level B https://www.spph-sx.com/zlfw1/zdzk.htm

50 hospitals with a matching national key specialty record.

Values written in Chinese are quoted as published by the source.

Questions about this condition

We cannot give medical advice, but we can answer questions about this page and about arranging treatment in China.

Ask us about this condition

ICD codes

Show the code table 13 ICD codes
Version Code Name in that version
ICD-10-WHO C18 Malignant neoplasm of colon
ICD-10-WHO C18.0 Caecum
ICD-10-WHO C18.1 Appendix
ICD-10-WHO C18.2 Ascending colon
ICD-10-WHO C18.3 Hepatic flexure
ICD-10-WHO C18.4 Transverse colon
ICD-10-WHO C18.5 Splenic flexure
ICD-10-WHO C18.6 Descending colon
ICD-10-WHO C18.7 Sigmoid colon
ICD-10-WHO C18.8 Overlapping lesion of colon
ICD-10-WHO C18.9 Colon, unspecified
ICD-10-WHO C19 Malignant neoplasm of rectosigmoid junction
ICD-10-WHO C20 Malignant neoplasm of rectum

Rows are the WHO ICD-10 entries for this condition, quoted as published.

Source & evidence

Source URL
https://wjw.fujian.gov.cn/xxgk/fgwj/zxwj/201904/P020190412506737868905.xlsx
Source scheme
https
Source type
Provincial health commission
Evidence level
A - said by a provincial health commission or university
Retrieved on
2026-09-24